Pharmacokinetics and Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers.

about

Pharmacokinetics and Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients with Lower Limb Infections and Healthy Adult Volunteers.

Item

http://www.wikidata.org/entity/Q40052714

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pharmacokinetics and Tissue Pe ...... and Healthy Adult Volunteers.

@en

type

Item

label

Pharmacokinetics and Tissue Pe ...... and Healthy Adult Volunteers.

@en

prefLabel

Pharmacokinetics and Tissue Pe ...... and Healthy Adult Volunteers.

@en

P1476

Pharmacokinetics and Tissue Pe ...... and Healthy Adult Volunteers.

@en

P2093

Arlinda Baummer-Carr

http://www.w3.org/2001/XMLSchema#string

Ashley K Shepard

http://www.w3.org/2001/XMLSchema#string

David P Nicolau

http://www.w3.org/2001/XMLSchema#string

James F Nugent

http://www.w3.org/2001/XMLSchema#string

Joseph L Kuti

http://www.w3.org/2001/XMLSchema#string

Marguerite L Monogue

http://www.w3.org/2001/XMLSchema#string

Sean M Stainton

http://www.w3.org/2001/XMLSchema#string

P2860

The Diabetic Foot: A Historical Overview and Gaps in Current Treatment

Diabetic foot disease: From the evaluation of the "foot at risk" to the novel diabetic ulcer treatment modalities

The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents

Prediction of creatinine clearance from serum creatinine

Pharmacokinetics and safety of CXA-101, a new antipseudomonal cephalosporin, in healthy adult male and female subjects receiving single- and multiple-dose intravenous infusions.

Impact of MIC range for Pseudomonas aeruginosa and Streptococcus pneumoniae on the ceftolozane in vivo pharmacokinetic/pharmacodynamic target.

Tissue penetration and pharmacokinetics of tigecycline in diabetic patients with chronic wound infections described by using in vivo microdialysis.

In vivo activities of ceftolozane, a new cephalosporin, with and without tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae, including strains with extended-spectrum β-lactamases, in the thighs of neutropenic mice.

Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli.

New developments in diagnosing and treating diabetic foot infections.

P31

scholarly article

P356

10.1128/AAC.01449-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28893779

http://www.w3.org/2001/XMLSchema#string

P932

5700352

http://www.w3.org/2001/XMLSchema#string